P-01

Identification of a marker for pancreatic precancerous lesions: diagnostic implication for early detection
Miho Sekai
(Department of Molecular Oncology, Graduate School of Medicine, Kyoto University)

P-02

Epitope-directed in silico screening and in vivo application of anti-OX40 agonistic antibody
Toshio Kitawaki
(Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University)

P-03

Monocyte-like cells promotes liver metastasis via THBS1-mediated CD8+ T cell inactivation in aggressive colorectal cancer
Mayuki Omatsu
(Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University)

P-04

Clinical data and mouse model of lung adenocarcinoma brain metastasis reveal efficacy of anti-PD-1/CTLA-4 therapy and involvement of cytotoxic T lymphocytes
Kazutaka Hosoya
(Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University)

P-05

Role of gut commensal translocation and molecular mimicry in autoantibody production in systemic lupus erythematosus
Masao Katsushima
(Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto
University)

P-06

Timing of the infusion of nivolumab for patients with recurrent or metastatic squamous cell carcinoma of the esophagus influences its efficacy
Motoo Nomura
(Department of Clinical Oncology, Graduate School of Medicine, Kyoto University)

P-07

Investigation of the roles of tertiary lymphoid structures and their potential as therapeutic target in kidney diseases
Takahisa Yoshikawa
(Department of Nephrology, Graduate School of Medicine, Kyoto University)

P-08

Depletion of tumor-infiltrating neutrophils invigorate antitumor immunity in PD-1 blockade-resistant urothelial cancer
Ryoichi Saito
(Department of Urology, Graduate School of Medicine, Kyoto University)

P-09

Generation of CTLs from iPSCs transduced with TCR genes: development of “TCR cassette” method
Seiji Nagano
(Institute for Life and Medical Sciences, Kyoto University)

P-10

Soluble CTLA-4 predominantly produced by Treg cells inhibits type 1 inflammation without hindering type 2 immunity for facilitating inflammation resolution
Motonao Osaki
(Laboratory of Immunopathogenesis, Institute for Life and Medical Sciences, Kyoto University)

P-11

Canonical BAF complex regulates the RUNX1-deriven oncogenic program in human T-cell acute lymphoblastic leukemia
Kazunari Aoki
(Stem cell genetics, Institute for Life and Medical Sciences, Kyoto University)

P-12

A landscape of full-length RNAs in human
Shruti Bhagat
(Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University)

P-13

Genome-wide iron-induced ferroptosis screen uncovers PRDX6 as a novel selenoprotein synthesis factor
Hiroaki Fujita
(Department of Molecular and Cellular Physiology, Graduate School of Medicine, Kyoto University)

P-14

Phenotypic analysis of peripheral tumor-reactive CD8+ T Cells expanded by PD-1 blockade in murine melanoma
Tomoko Hirano
(Department of Dermatology, Graduate School of Medicine, Kyoto University)

P-15

Artificial intelligence-based spatial analysis of tertiary lymphoid structures (TLSs) and the efficacy of immunotherapy for endometrial cancer
Junzo Hamanishi
(Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University)

P-16

Development of antitumor immune control strategy by nucleic acid medicine targeting RNA structure
Takuya Uehata
(Department of Medical Chemistry, Graduate School of Medicine, Kyoto University)

P-17

Aiming at establishment of immunotherapeutic approach that balance anti-tumor effect and irAE management
Hirotake Tsukamoto
Kosaku Murakami
(Division of Clinical Immunology and Cancer Immunotherapy, Center for Cancer Immunotherapy and Immunobiology (CCII), Graduate School of Medicine, Kyoto University)

P-18

Combination therapy with Trifluridine/Tipiracil and ATR–CHK1–WEE1 pathway inhibition against TP53–mutant esophageal cancer
Trang Nguyen
(Division of Clinical Pharmacology and Cancer Immunotherapy, Center for Cancer Immunotherapy and Immunobiology (CCII), Graduate School of Medicine, Kyoto University)

P-19

Informatics-based characterization of T cell exhaustion associated with human breast cancer
Kei Iida
(Informatics Platform, Center for Cancer Immunotherapy and Immunobiology (CCII), Graduate School of Medicine, Kyoto University)Asuka Yajima(Department of Life Science, Faculty of Science and Engineering, Kindai University)

P-20

Spermidine rescues ER stress-mediated dysfunction in tumor-infiltrating CD8+ T cells by promoting BiP chaperone activity in aged mice
Yixin ZOU
(Department of Immunology and Genomic Medicine, Center for Cancer Immunotherapy and Immunobiology (CCII), Graduate School of Medicine, Kyoto University)

P-21

Near-infrared photoimmunotherapy augments the antitumor effect of in situ vaccine using a unique nanoparticulate Toll-like receptor 9 ligand
Ken Takahashi
(Division of Cancer Immunotherapy, Center for Cancer Immunotherapy and Immunobiology (CCII), Graduate School of Medicine, Kyoto University)Hiroaki Yaku(Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University)

P-22

Human iPSC-based artificial thymus as a new platform for in vitro T cell generation
Yann Pretemer
(Center for iPS cell Research and Application (CiRA), Kyoto University)

P-23

The generation of T cells from iPSCs for immunotherapy
Shin Kaneko
(Center for iPS cell Research and Application (CiRA), Kyoto University)